Literature DB >> 25154329

Semaphorins in cardiovascular medicine.

Davide Corà1, Elena Astanina1, Enrico Giraudo2, Federico Bussolino3.   

Abstract

During organogenesis, patterning is primarily achieved by the combined actions of morphogens. Among these, semaphorins represent a general system for establishing the appropriate wiring architecture of biological nets. Originally discovered as evolutionarily conserved steering molecules for developing axons, subsequent studies on semaphorins expanded their functions to the cardiovascular and immune systems. Semaphorins participate in cardiac organogenesis and control physiological vasculogenesis and angiogenesis, which result from a balance between pro- and anti-angiogenic signals. These signals are altered in several diseases. In this review, we discuss the role of semaphorins in vascular biology, emphasizing the mechanisms by which these molecules control vascular patterning and lymphangiogenesis, as well as in genetically inherited and degenerative vascular diseases.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  angiogenesis; cardiac diseases; endothelial cells; plexins; vascular diseases

Mesh:

Substances:

Year:  2014        PMID: 25154329     DOI: 10.1016/j.molmed.2014.07.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  7 in total

Review 1.  Endothelial mechanotransduction in cardiovascular development and regeneration: emerging approaches and animal models.

Authors:  Susana Cavallero; Ana M Blázquez-Medela; Sandro Satta; Tzung K Hsiai
Journal:  Curr Top Membr       Date:  2021-10-12       Impact factor: 2.025

2.  Sema3A promotes the resolution of cardiac inflammation after myocardial infarction.

Authors:  Marieke Rienks; Paolo Carai; Nicole Bitsch; Mark Schellings; Maarten Vanhaverbeke; Johan Verjans; Ilona Cuijpers; Stephane Heymans; Anna Papageorgiou
Journal:  Basic Res Cardiol       Date:  2017-05-24       Impact factor: 17.165

Review 3.  CD100 Effects in Macrophages and Its Roles in Atherosclerosis.

Authors:  Maria C A Luque; Mariana K Galuppo; Janaina Capelli-Peixoto; Beatriz S Stolf
Journal:  Front Cardiovasc Med       Date:  2018-09-28

4.  Semaphorin3E-PlexinD1 signaling in coronary artery and lymphatic vessel development with clinical implications in myocardial recovery.

Authors:  Kazuaki Maruyama; Kazuaki Naemura; Yuichiro Arima; Yasunobu Uchijima; Hiroaki Nagao; Kenji Yoshihara; Manvendra K Singh; Akiyoshi Uemura; Fumio Matsuzaki; Yutaka Yoshida; Yukiko Kurihara; Sachiko Miyagawa-Tomita; Hiroki Kurihara
Journal:  iScience       Date:  2021-03-15

5.  Semaphorin3f as a cardiomyocyte derived regulator of heart chamber development.

Authors:  Rami Halabi; Paula Bernice Cechmanek; Carrie Lynn Hehr; Sarah McFarlane
Journal:  Cell Commun Signal       Date:  2022-08-19       Impact factor: 7.525

6.  Gene expression of vascular endothelial growth factor A and hypoxic adaptation in Tibetan pig.

Authors:  Bo Zhang; Yangzong Qiangba; Peng Shang; Yunfeng Lu; Yuzeng Yang; Zhixiu Wang; Hao Zhang
Journal:  J Anim Sci Biotechnol       Date:  2016-04-02

7.  Endothelial Semaphorin 3F Maintains Endothelial Barrier Function and Inhibits Monocyte Migration.

Authors:  Huayu Zhang; Dianne Vreeken; Abidemi Junaid; Gangqi Wang; Wendy M P J Sol; Ruben G de Bruin; Anton Jan van Zonneveld; Janine M van Gils
Journal:  Int J Mol Sci       Date:  2020-02-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.